AU2001277754A1 - Proline derivatives and use thereof as drugs - Google Patents

Proline derivatives and use thereof as drugs

Info

Publication number
AU2001277754A1
AU2001277754A1 AU2001277754A AU2001277754A AU2001277754A1 AU 2001277754 A1 AU2001277754 A1 AU 2001277754A1 AU 2001277754 A AU2001277754 A AU 2001277754A AU 2001277754 A AU2001277754 A AU 2001277754A AU 2001277754 A1 AU2001277754 A1 AU 2001277754A1
Authority
AU
Australia
Prior art keywords
drugs
proline derivatives
proline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001277754A
Other versions
AU2001277754B2 (en
Inventor
Fumihiko Akahoshi
Yoshiharu Hayashi
Hiroshi Kitajima
Hiroshi Sakashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Priority claimed from PCT/JP2001/006906 external-priority patent/WO2002014271A1/en
Publication of AU2001277754A1 publication Critical patent/AU2001277754A1/en
Application granted granted Critical
Publication of AU2001277754B2 publication Critical patent/AU2001277754B2/en
Assigned to MITSUBISHI TANABE PHARMA CORPORATION reassignment MITSUBISHI TANABE PHARMA CORPORATION Request to Amend Deed and Register Assignors: MITSUBISHI PHARMA CORPORATION
Assigned to MITSUBISHI TANABE PHARMA CORPORATION reassignment MITSUBISHI TANABE PHARMA CORPORATION Request to Amend Deed and Register Assignors: MITSUBISHI PHARMA CORPORATION
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2001277754A 2000-08-10 2001-08-10 Proline derivatives and use thereof as drugs Expired AU2001277754B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-243217 2000-08-10
JP2000243217 2000-08-10
JP2000-400296 2000-12-28
JP2000400296 2000-12-28
PCT/JP2001/006906 WO2002014271A1 (en) 2000-08-10 2001-08-10 Proline derivatives and use thereof as drugs

Publications (2)

Publication Number Publication Date
AU2001277754A1 true AU2001277754A1 (en) 2002-05-23
AU2001277754B2 AU2001277754B2 (en) 2005-09-29

Family

ID=26597757

Family Applications (2)

Application Number Title Priority Date Filing Date
AU7775401A Pending AU7775401A (en) 2000-08-10 2001-08-10 Proline derivatives and use thereof as drugs
AU2001277754A Expired AU2001277754B2 (en) 2000-08-10 2001-08-10 Proline derivatives and use thereof as drugs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU7775401A Pending AU7775401A (en) 2000-08-10 2001-08-10 Proline derivatives and use thereof as drugs

Country Status (17)

Country Link
US (3) US7074794B2 (en)
EP (3) EP1950199B1 (en)
JP (1) JP4101053B2 (en)
KR (1) KR100817378B1 (en)
CN (1) CN1186322C (en)
AT (3) ATE450504T1 (en)
AU (2) AU7775401A (en)
BR (1) BRPI0113146B8 (en)
CA (1) CA2418656C (en)
DE (2) DE60136188D1 (en)
DK (1) DK1308439T3 (en)
ES (2) ES2334858T3 (en)
HU (1) HU227882B1 (en)
NO (3) NO325449B1 (en)
NZ (1) NZ524618A (en)
PT (1) PT1308439E (en)
WO (1) WO2002014271A1 (en)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
EE05735B1 (en) * 2001-02-24 2015-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthin derivatives, their production and utilisation as medicine
ATE395912T1 (en) 2001-03-27 2008-06-15 Merck & Co Inc DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
JPWO2003024942A1 (en) * 2001-09-14 2004-12-24 三菱ウェルファーマ株式会社 Thiazolidine derivatives and their pharmaceutical uses
US7074798B2 (en) 2002-02-25 2006-07-11 Eisai Co., Ltd Xanthine derivative and DPPIV inhibitor
HUP0200849A2 (en) 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetyl-pyrrolidine-2-carbonitrile derivatives, pharmaceutical compositions containing them and process for producing them
RU2005102004A (en) 2002-06-27 2005-10-20 Шеринг Акциенгезельшафт (De) SUBSTITUTED QUINOLINS AS CCR5 RECEPTOR ANTAGONISTS
TW200404796A (en) * 2002-08-19 2004-04-01 Ono Pharmaceutical Co Nitrogen-containing compound
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7495005B2 (en) 2002-08-22 2009-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthine derivatives, their preparation and their use in pharmaceutical compositions
US7569574B2 (en) 2002-08-22 2009-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
EP1551811A1 (en) * 2002-10-17 2005-07-13 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
US7482337B2 (en) 2002-11-08 2009-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
DE10254304A1 (en) * 2002-11-21 2004-06-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New xanthine derivatives, their production and their use as medicines
JP2005170792A (en) * 2002-11-22 2005-06-30 Mitsubishi Pharma Corp L-proline derivative and use of the same as medicine
UY28103A1 (en) * 2002-12-03 2004-06-30 Boehringer Ingelheim Pharma NEW IMIDAZO-PIRIDINONAS REPLACED, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS
US7109192B2 (en) 2002-12-03 2006-09-19 Boehringer Ingelheim Pharma Gmbh & Co Kg Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
JPWO2004069828A1 (en) * 2003-02-04 2006-05-25 三菱ウェルファーマ株式会社 Piperidine compounds and their pharmaceutical uses
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (en) 2003-03-03 2005-01-07 Vertex Pharma COMPOUNDS DERIVED FROM 2- (REPLACED CILO) -1- (AMINO OR REPLACED OXI) -CHINAZOLINE, INHIBITORS OF IONIC SODIUM AND CALCIUM VOLTAGE DEPENDENTS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF ACUTE PAIN, CHRONIC, NEU
US7550590B2 (en) * 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1619193A4 (en) * 2003-04-18 2010-08-11 Ono Pharmaceutical Co Spiropiperidine compound and medicinal use thereof
EA009291B1 (en) 2003-05-05 2007-12-28 Пробиодруг Аг Use of effectors of glutaminyl and glutamate cyclases
DK2206496T3 (en) 2003-05-05 2014-12-15 Probiodrug Ag Screening of inhibitors of pyroglutamic acid formation in amyloid beta peptide
CA2524531A1 (en) * 2003-05-14 2004-12-02 Merck And Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
AU2003902946A0 (en) * 2003-06-12 2003-06-26 Fujisawa Pharmaceutical Co., Ltd. Dpp-iv inhibitor
US7566707B2 (en) 2003-06-18 2009-07-28 Boehringer Ingelheim International Gmbh Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
ES2355105T3 (en) 2003-06-20 2011-03-22 F. Hoffmann-La Roche Ag REQUEST (2,1-A) ISOQUINOLINE AS INHIBITORS OF THE DPP-IV.
WO2005030121A2 (en) * 2003-06-30 2005-04-07 Hif Bio, Inc. Compounds, compositions and methods
US20050065148A1 (en) * 2003-08-13 2005-03-24 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7205409B2 (en) 2003-09-04 2007-04-17 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
WO2005026148A1 (en) 2003-09-08 2005-03-24 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
NZ546322A (en) 2003-10-15 2008-11-28 Probiodrug Ag Use of effectors of glutaminyl and glutamate cyclases
JP2007509898A (en) 2003-11-03 2007-04-19 プロビオドルグ エージー Useful combinations for the treatment of neurological disorders
KR20150132601A (en) 2003-11-17 2015-11-25 노파르티스 아게 Use of dipeptidyl peptidase iv inhibitors
DE10355304A1 (en) 2003-11-27 2005-06-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel 8- (piperazin-1-yl) and 8 - ([1,4] diazepan-1-yl) xanthines, their preparation and their use as pharmaceuticals
CN1898235A (en) * 2003-12-24 2007-01-17 普罗西迪恩有限公司 Heterocyclic derivatives as gpcr receptor agonists
PT3366283T (en) 2004-01-20 2021-12-02 Novartis Ag Direct compression formulation and process
WO2005073186A1 (en) * 2004-01-29 2005-08-11 Ono Pharmaceutical Co., Ltd. Pyrrolidine derivatives
RS52163B (en) * 2004-02-05 2012-08-31 Kyorin Pharmaceutical Co. Ltd. Bicycloester derivative
KR101099206B1 (en) 2004-02-05 2011-12-27 프로비오드룩 아게 Novel Inhibitors of Glutaminyl Cyclase
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
CA2554378A1 (en) * 2004-02-18 2005-08-25 Kyorin Pharmaceutical Co., Ltd. Bicycloamide derivative
DE102004009039A1 (en) * 2004-02-23 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8- [3-Amino-piperidin-1-yl] xanthines, their preparation and use as pharmaceuticals
JP4689599B2 (en) * 2004-02-27 2011-05-25 杏林製薬株式会社 Bicyclo derivative
US7348346B2 (en) 2004-03-08 2008-03-25 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7393847B2 (en) 2004-03-13 2008-07-01 Boehringer Ingleheim International Gmbh Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
WO2005095381A1 (en) 2004-03-15 2005-10-13 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7179809B2 (en) * 2004-04-10 2007-02-20 Boehringer Ingelheim International Gmbh 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
US7439370B2 (en) * 2004-05-10 2008-10-21 Boehringer Ingelheim International Gmbh Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
CN1968949B (en) * 2004-05-12 2011-05-04 辉瑞产品公司 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
MXPA06013114A (en) 2004-05-12 2007-02-28 Pfizer Prod Inc Proline derivatives and their use as dipeptidyl peptidase iv inhibitors.
FR2870538B1 (en) * 2004-05-19 2006-07-14 Servier Lab NOVEL DERIVATIVES OF PYRROLIDINES AND THIAZOLIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2005118555A1 (en) * 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DE102004030502A1 (en) 2004-06-24 2006-01-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel imidazoles and triazoles, their preparation and use as medicines
WO2006008644A1 (en) * 2004-07-13 2006-01-26 Pfizer Products Inc. Antidiabetic compounds
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7842707B2 (en) 2004-07-23 2010-11-30 Nuada, Llc Peptidase inhibitors
JP5135795B2 (en) 2004-08-27 2013-02-06 小野薬品工業株式会社 COMPOUND CONTAINING BASIC GROUP AND USE THEREOF
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
DE102004043944A1 (en) 2004-09-11 2006-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel 8- (3-amino-piperidin-1-yl) -7- (but-2-ynyl) -xanthines, their preparation and their use as pharmaceuticals
DE102004044221A1 (en) 2004-09-14 2006-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 3-methyl-7-butynyl xanthines, their preparation and their use as pharmaceuticals
FR2876688B1 (en) * 2004-10-14 2007-03-16 Aventis Pharma Sa NEW PRODUCT, PROCESS AND INTERMEDIATES FOR PREPARING AZETIDINE DERIVATIVES
DE102004054054A1 (en) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
WO2006068978A2 (en) 2004-12-21 2006-06-29 Takeda Pharmaceutial Company Limited Dipeptidyl peptidase inhibitors
WO2006073167A1 (en) * 2005-01-07 2006-07-13 Ono Pharmaceutical Co., Ltd. Pyrrolidine derivatives
DOP2006000008A (en) * 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
CA2598301C (en) * 2005-02-18 2013-05-28 Mitsubishi Pharma Corporation Salt of proline derivative, solvate thereof, and production method thereof
NZ556629A (en) * 2005-03-03 2010-04-30 Janssen Pharmaceutica Nv Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
DE602006016244D1 (en) 2005-03-08 2010-09-30 Janssen Pharmaceutica Nv DIAZASPIRO Ä4,4Ü NONANDERIVATES AS NEUROKININ (NK1) ANTAGONISTS
EP1879881A2 (en) * 2005-04-14 2008-01-23 Bristol-Myers Squibb Company Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
EA200702208A1 (en) 2005-04-22 2008-04-28 Алантос Фармасьютиклз Холдинг, Инк. DIPEPTIDYLPEPTIDASE-IV INHIBITORS
CA2605847C (en) * 2005-04-26 2014-02-04 Mitsubishi Tanabe Pharma Corporation Ddp-iv inhibitors for the treatment of postprandial hyperlipidemia
CA2610361C (en) * 2005-06-03 2013-11-26 Mitsubishi Tanabe Pharma Corporation Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control
WO2006133160A2 (en) 2005-06-06 2006-12-14 Georgetown University Compositions and methods for lipo modeling
MY152185A (en) 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
DE102005035891A1 (en) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals
EP1932839A4 (en) * 2005-09-06 2014-09-10 Shionogi & Co Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
SI1942898T2 (en) 2005-09-14 2014-08-29 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
KR101368988B1 (en) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 Dipeptidyl peptidase inhibitors
PT1961744E (en) 2005-11-18 2013-05-15 Ono Pharmaceutical Co Basic group-containing compound and use thereof
GB0526291D0 (en) 2005-12-23 2006-02-01 Prosidion Ltd Therapeutic method
AU2007224066B2 (en) * 2006-03-08 2011-10-27 Kyorin Pharmaceutical Co., Ltd. Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1999120B1 (en) * 2006-03-28 2012-06-27 High Point Pharmaceuticals, LLC Benzothiazoles having histamine h3 receptor activity
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
MX2008013120A (en) 2006-04-11 2008-10-27 Arena Pharm Inc Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual.
TW200815351A (en) * 2006-05-02 2008-04-01 Astrazeneca Ab Novel compounds
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
KR101541791B1 (en) 2006-05-04 2015-08-04 베링거 인겔하임 인터내셔날 게엠베하 Polymorphs
PE20110235A1 (en) 2006-05-04 2011-04-14 Boehringer Ingelheim Int PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE
WO2007132846A1 (en) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
EA016054B1 (en) * 2006-06-16 2012-01-30 Х. Лундбекк А/С Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
EP2057160A1 (en) 2006-08-08 2009-05-13 Boehringer Ingelheim International GmbH Pyrrolo [3, 2 -d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
WO2008114857A1 (en) * 2007-03-22 2008-09-25 Kyorin Pharmaceutical Co., Ltd. Method for producing aminoacetylpyrrolidinecarbonitrile derivative
AU2008233548B2 (en) 2007-04-03 2011-12-01 Mitsubishi Tanabe Pharma Corporation Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener
CL2008003653A1 (en) * 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
PE20140960A1 (en) 2008-04-03 2014-08-15 Boehringer Ingelheim Int FORMULATIONS INVOLVING A DPP4 INHIBITOR
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
UY32030A (en) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
BRPI0916997A2 (en) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh DPP-4 INHIBITOR AND ITS USE
US8476470B2 (en) * 2008-08-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Process for production of bicyclo[2.2.2]octylamine derivative
US20110152342A1 (en) * 2008-08-14 2011-06-23 Hiroshi Uchida Stabilized pharmaceutical composition
EA031225B1 (en) 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Dpp-4 inhibitors for wound healing
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
MX2011004258A (en) 2008-10-22 2011-06-01 Merck Sharp & Dohme Novel cyclic benzimidazole derivatives useful anti-diabetic agents.
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
NZ592924A (en) 2008-12-23 2014-05-30 Boehringer Ingelheim Int Salt forms of a xanthine derivative
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
AR075204A1 (en) 2009-01-29 2011-03-16 Boehringer Ingelheim Int DPP-4 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, USEFUL TO TREAT METABOLIC DISEASES IN PEDIATRIC PATIENTS, PARTICULARLY MELLITUS DIABETES TYPE 2
JP2012517977A (en) 2009-02-13 2012-08-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング An anti-diabetic drug comprising a DPP-4 inhibitor (linagliptin) optionally in combination with other anti-diabetic drugs
JPWO2010110436A1 (en) 2009-03-27 2012-10-04 杏林製薬株式会社 Matrix-type sustained-release preparation containing basic additives
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
CA2782179C (en) 2009-11-27 2020-06-23 Boehringer Ingelheim International Gmbh Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
US9572806B2 (en) * 2009-12-18 2017-02-21 Mitsubishi Tanabe Pharma Corporation Elution-stabilized preparation
EP2538784B1 (en) 2010-02-25 2015-09-09 Merck Sharp & Dohme Corp. Benzimidazole derivatives useful anti-diabetic agents
JP2013522279A (en) 2010-03-18 2013-06-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination of GPR119 agonist and DDP-IV inhibitor linagliptin for use in the treatment of diabetes and related conditions
AU2011237775A1 (en) 2010-04-06 2012-11-22 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
GB201006166D0 (en) * 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
NZ602921A (en) 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
JP5843855B2 (en) 2010-06-24 2016-01-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Diabetes therapy
JP5941916B2 (en) 2010-09-22 2016-06-29 アリーナ ファーマシューティカルズ， インコーポレイテッド GPR119 receptor modulators and treatment of disorders related thereto
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
CN103619334A (en) * 2011-01-19 2014-03-05 朱红文 Thiazolidine derivatives and therapeutic use thereof
WO2012116145A1 (en) 2011-02-25 2012-08-30 Merck Sharp & Dohme Corp. Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
JP5863789B2 (en) * 2011-06-01 2016-02-17 田辺三菱製薬株式会社 Method for producing pyrazole derivative
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
ES2713566T3 (en) 2011-07-15 2019-05-22 Boehringer Ingelheim Int Derivative of substituted dinamic quinazoline, its preparation and its use in pharmaceutical compositions for the treatment of type I and II diabetes
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
CN103420981A (en) * 2012-05-21 2013-12-04 中国医学科学院药物研究所 Substituted-pyrrolidinyl-contained thiomorpholine compounds
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
MX2015001500A (en) 2012-08-02 2015-04-08 Merck Sharp & Dohme Antidiabetic tricyclic compounds.
US9518048B2 (en) 2012-08-31 2016-12-13 Glenmark Pharmaceuticals Limited Process for the preparation of teneligliptin
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
JP2016516004A (en) 2013-02-22 2016-06-02 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Antidiabetic bicyclic compound
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
JP6348568B2 (en) 2013-03-15 2018-06-27 モンサント テクノロジー エルエルシー N-, C-disubstituted azoles for nematode pest control
CN104177295B (en) * 2013-05-24 2016-08-17 南京华威医药科技开发有限公司 Preparation method for Ge Lieting key intermediate 1-(3-methyl isophthalic acid-phenyl-5-pyrazolyl) piperazine
CN104211685A (en) * 2013-05-29 2014-12-17 中国医学科学院药物研究所 Thiomorpholine compounds containing substituted pyrrole alkyl groups
CN103275010A (en) * 2013-05-30 2013-09-04 上海皓元生物医药科技有限公司 Preparation method of 1-(3-methyl-1-phenyl-1H-pyrazolyl-5-yl)piperazine
CN104230917B (en) * 2013-06-24 2017-04-05 南京华威医药科技开发有限公司 A kind of hydrate and its production method of proline derivative salt
WO2015019238A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one
WO2015019239A1 (en) 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2015063709A1 (en) 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
ES2950384T3 (en) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Medical use of a DPP-4 inhibitor
CN105085358A (en) * 2014-05-07 2015-11-25 中国医学科学院药物研究所 4-substituted pyrrolidine formyl thiomorpholine DPP-IV (Dipeptidyl Peptidase IV) inhibitor
CN105085359A (en) * 2014-05-07 2015-11-25 中国医学科学院药物研究所 Nitrogen-containing heterocyclic substituted pyrrolidine formyl thiomorpholin DPP-IV inhibitor
WO2015173779A1 (en) 2014-05-16 2015-11-19 Micro Labs Limited Process for the preparation of teneligliptin and its novel intermediates
CN105294673B (en) * 2014-06-18 2018-04-13 四川科伦药物研究院有限公司 A kind of hydrobromic acid replaces the synthetic method of Ge Lieting
CN104496876A (en) * 2015-01-13 2015-04-08 佛山市赛维斯医药科技有限公司 Hydroxyl diamantane amide derivative, preparation method and use thereof
CN104529856A (en) * 2015-01-13 2015-04-22 佛山市赛维斯医药科技有限公司 Nitro adamantine amide derivative and preparing method and application thereof
CN104529858A (en) * 2015-01-13 2015-04-22 佛山市赛维斯医药科技有限公司 Derivative with halogeneated and amides and preparation method and application thereof
KR20180006881A (en) 2015-03-09 2018-01-19 인테크린 테라퓨틱스, 아이엔씨. Methods for the treatment of nonalcoholic fatty liver disease and / or fat dystrophy
EP3383390A4 (en) * 2015-12-02 2019-11-20 Astraea Therapeutics, LLC Piperidinyl nociceptin receptor compounds
US10112924B2 (en) 2015-12-02 2018-10-30 Astraea Therapeutics, Inc. Piperdinyl nociceptin receptor compounds
CN109310697A (en) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 The combination of Li Gelieting and melbine
WO2018106518A1 (en) 2016-12-06 2018-06-14 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
US10968232B2 (en) 2016-12-20 2021-04-06 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds
WO2018162722A1 (en) 2017-03-09 2018-09-13 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Dpp-4 inhibitors for use in treating bone fractures
AU2018249822A1 (en) 2017-04-03 2019-10-31 Coherus Biosciences Inc. PPArgamma agonist for treatment of progressive supranuclear palsy
WO2019079578A1 (en) * 2017-10-19 2019-04-25 Amgen Inc. Benzimidazole derivatives and their uses
JP6985179B2 (en) * 2018-02-27 2021-12-22 田辺三菱製薬株式会社 Method for producing proline amide compound
CN108997308A (en) * 2018-07-09 2018-12-14 西藏大学 A kind of benzimidazoles derivative and its preparation method and application
KR102494848B1 (en) 2018-10-10 2023-02-02 주식회사 파마코스텍 Crystal form I of teneligliptin ditosylate dihydrate and preparation process thereof
KR20200127480A (en) 2019-05-02 2020-11-11 연성정밀화학(주) Crystalline Forms of Teneligliptin Edisylate and Process of Preparing the Same
CN116745291A (en) 2020-12-17 2023-09-12 阿斯利康(瑞典)有限公司 N- (2- (4-cyanothiazolidin-3-yl) -2-oxoethyl) -quinoline-4-carboxamide
CN118076585A (en) * 2021-07-23 2024-05-24 国家医疗保健研究所 Gram negative bacteria efflux pump inhibitors
WO2024204772A1 (en) * 2023-03-31 2024-10-03 田辺三菱製薬株式会社 Pharmaceutical composition for treatment of multisystem atrophy or inhibiting progress of multisystem atrophy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
DE19823831A1 (en) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim New pharmaceutical use of isoleucyl thiazolidide and its salts
US6399629B1 (en) * 1998-06-01 2002-06-04 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
JP2000243217A (en) 1999-02-23 2000-09-08 Matsushita Electric Works Ltd Semiconductor diamond electron emitting element
CN1362953A (en) * 2000-02-05 2002-08-07 沃泰克斯药物股份有限公司 Pyrazole compositions useful as inhibitors of ERK
WO2002022610A1 (en) * 2000-09-15 2002-03-21 Vertex Pharmaceuticals Incorporated Isoxazoles and their use as inhibitors of erk

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU8198901A (en) Novel heteroaryl derivatives and use thereof as medicaments
AU7240201A (en) Aza- and polyazanthranyl amides and their use as medicaments
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001245316A1 (en) Naphtalene derivatives and their pharmaceutical use
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
AU8975801A (en) Novel indole derivatives and their use as medicaments
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU4432001A (en) Trityl-type compounds and their use
AU2001243601A1 (en) Caprolactam derivatives and uses thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines